What are the recommended dose and dosing interval of cefaclor oral suspension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefaclor Suspension Dosing

For pediatric patients, cefaclor suspension should be dosed at 20 mg/kg/day divided every 8 hours (three times daily) for most infections, or 40 mg/kg/day divided every 8 hours for more serious infections including otitis media, with a maximum daily dose of 1 gram. 1

Standard Dosing Regimen

The FDA-approved dosing from the drug label provides the authoritative framework 1:

Pediatric Dosing (Every 8 Hours)

  • Mild to moderate infections: 20 mg/kg/day divided into three doses (every 8 hours)

    • Example: 9 kg child = 1/2 teaspoon (125 mg/5 mL) three times daily
    • Example: 18 kg child = 1 teaspoon (125 mg/5 mL) three times daily
  • More serious infections, otitis media, or less susceptible organisms: 40 mg/kg/day divided into three doses (every 8 hours), maximum 1 g/day

    • Example: 9 kg child = 1 teaspoon (125 mg/5 mL) three times daily
    • Example: 18 kg child = 1 teaspoon (250 mg/5 mL) three times daily

Alternative Twice-Daily Dosing

For otitis media and pharyngitis specifically, the total daily dose may be divided and given every 12 hours (twice daily) 1. This improves compliance while maintaining efficacy:

  • Pharyngitis (20 mg/kg/day): 18 kg child = 1/2 teaspoon (375 mg/5 mL) twice daily
  • Otitis media (40 mg/kg/day): 9 kg child = 1/2 teaspoon twice daily; 18 kg child = 1 teaspoon twice daily

Adult Dosing

  • Standard: 250 mg every 8 hours
  • Severe infections or less susceptible organisms: 500 mg every 8 hours 1

Duration of Therapy

  • Streptococcal infections: Minimum 10 days 1
  • Otitis media: 10 days 2, 3
  • Most other infections: Continue for 3-5 days after signs of infection disappear 4

Important Clinical Considerations

Limitations of Cefaclor

A critical caveat: Cefaclor has poor activity against H. influenzae, fair activity against penicillin-susceptible pneumococci, and no activity against drug-resistant S. pneumoniae (DRSP), resulting in poor overall efficacy against bacterial respiratory tract pathogens 5. This significantly limits its utility as a first-line agent for respiratory infections despite FDA approval for these indications.

Practical Administration

  • Administer with or without food (food delays but does not reduce absorption) 6
  • Suspension remains stable after reconstitution per label instructions 1
  • The suspension formulation is generally well-tolerated in children 7

Renal Impairment

Dosage adjustment is typically not required in renal impairment, though cefaclor is primarily renally eliminated 1, 6

Clinical Efficacy Data

Research supports the labeled dosing, with studies showing 93-97% bacteriologic cure rates at 40 mg/kg/day for otitis media 3, though one study suggested mild preference for alternative agents like trimethoprim-sulfamethoxazole due to twice-daily dosing and lower cost 2.

References

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Research

Evaluation of cefaclor.

American journal of hospital pharmacy, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.